As announced by the Ministry of Health (MOH), there is an additional one (1) clinical trial study involving the COVID-19 vaccine that has been approved by the National Pharmaceutical Regulatory Division (NPRA) on 28 May 2021. This clinical study involves the product SARS-CoV-2 Vaccine ( Vero Cells), Inactivated, 5μg/0.5mL. Manufactured by Shenzhen Kangtai Biological Products Co., Ltd. in China.
If you have not been vaccinated against the COVID-19 and are interested to participate in this vaccine study at the University of Malaya Medical Centre, please call/ WhatsApp 018-3835515.
Almost all of the study visits will be conducted on weekends and travel expenses of up to RM600 are provided if selected.
Further information, please refer Covid-19 Vaccine Volunteers (BI) / Covid_19 Vaccine Volunteers (Others)